SABCS 2025: Latest developments in multigene testing in early breast cancer
Dr Cristina Saura speaks to ecancer about research which has shown for the first time that breast milk from breast cancer patients could become a new tool for early diagnosis.
She explains that the study began 5 years ago when a breast cancer patient posed the question, "Could I transmit the breast cancer to my baby through the breast milk?". After analysing a sample, and comparing it with a sample taken 18 months before the diagnosis, the same mutations identified within the tumour were also discovered.
Dr Saura details that an NGS-based genomic panel was built with Dr Ana Vivancos and was used to detect the most frequent mutations present in women with breast cancer diagnosed before the age of 45.
She reports the findings of the study which found that mutations were detected in the samples of breast milk of 13 of the 15 patients analysed.
SABCS 2025: Latest developments in multigene testing in early breast cancer
AI-Based sTIL analysis expands identification of HER2+ BC patients benefiting from pertuzumab
Insights into germline genetic screening of breast cancer patients
Hormonal receptor positive breast cancer adjuvant and metastatic indications
Clinical behaviour of breast cancer in young BRCA carriers and prognostic impact of the timing of genetic testing
Bone disease evaluation of newly diagnosed MM with combined use of 18F-FDG PET/CT and whole-body diffusion weighted MRI
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
SABCS 2023: Latest breast cancer diagnostics guidelines
Somatic mutation profile of breast cancer in Uganda